Table 1.
Baseline Characteristics and Clinical Outcomes of Patients With AP, Divided by Status of SARS-CoV-2 PCR Testing
| Variable | SARS-CoV-2 PCR negative (n = 61) | SARS-CoV-2 PCR positive (n = 14) | P value |
|---|---|---|---|
| Age, y, mean (±SD) | 48.4 (±14.1) | 55.2 (±14.8) | .76 |
| Sex: female, n (%) | 34 (56) | 7 (50) | .77 |
| Race: white, n (%) | 48 (79) | 11 (79) | .77 |
| BMI ≥30 kg/m2, n (%) | 18 (29.5) | 4 (28.6) | .95 |
| CCI score, n (%) | |||
| 1–2 | 57 (93.4) | 9 (64.3) | .003 |
| 3–4 | 4 (6.6) | 5 (35.7) | |
| ≥5 | 0 | 0 | |
| Etiology, n (%) | |||
| Alcohol | 39 (64) | 3 (29) | <.0001 |
| Gallstone | 19 (31) | 1 (7) | |
| Idiopathic | 1 (2) | 8 (57) | |
| Other | 2 (3) | 1 (7) | |
| BISAP score, n (%) | |||
| <3 | 58 (95) | 8 (57) | <.0001 |
| ≥3 | 3 (5) | 6 (43) | |
| Pattern, n (%) | |||
| Interstitial | 55 (90) | 12 (86) | .63 |
| Necrotizing | 6 (10) | 2 (14) | |
| Organ failure, n (%) | |||
| None | 47 (77) | 4 (29) | <.0001 |
| Isolated circulatory | 0 | 0 | |
| Isolated respiratory | 2 (3) | 0 | |
| Isolated renal | 9 (15) | 2 (14) | |
| Renal and respiratory combined | 3 (5) | 6 (43) | |
| Triple organ failure | 0 | 2 (14) | |
| Persistent organ failure, n (%) | 5 (8) | 8 (57) | <.0001 |
| Infected necrosis, n (%) | 3 (5) | 1 (7) | .74 |
| Splanchnic venous thrombosis, n (%) | 4 (7) | 2 (14) | .31 |
| Acute endocrine insufficiency, n (%) | 4 (7) | 1 (7) | >.99 |
| ICU stay, d, mean (±SD) | 0.75 (±3.6) | 3.6 (±4.3) | .35 |
| Mechanical ventilation, n (%) | |||
| None | 58 (95) | 8 (57) | .62 |
| Noninvasive | 3 (5) | 4 (29) | |
| Invasive | 0 | 2 (14) | |
| LOS, mean (±SD) | 6.5 (±6.7) | 10.8 (±7.2) | .67 |
| Mortality, n (%) | 1 (2) | 3 (21) | .02 |
BMI, body mass index; CCI, Charlson Comorbidity Index; ICU, intensive care unit; LOS, length of stay; SD, standard deviation.